Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean Follmann

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Statistics in Medicine|August 10, 2018
Reliably picking the best endpointDean Follmann
Statistics in Medicine|May 8, 2021
CommentDean Follmann
Biometrics|September 16, 2021
Discussion on "estimating vaccine efficacy over time after a randomized study is unblinded" by Anastasios A. Tsiatis and Marie DavidianDean Follmann
Biometrics|December 13, 2006
Augmented designs to assess immune response in vaccine trialsDean Follmann
Biometrics|January 8, 2011
An augmented probit model for missing predictable covariates in quantal bioassay with small sample sizeDean Follmann, Martha Nason
Biometrics|November 26, 2009
Design and analysis of crossover trials for absorbing binary endpointsMartha Nason, Dean Follmann
Journal of Multivariate Analysis|November 30, 2011
A test of location for exchangeable multivariate normal data with unknown correlationDean Follmann, Michael Proschan
Biostatistics (Oxford, England)|August 14, 2024
Exposure proximal immune correlates analysisYing Huang, Dean Follmann
Statistics in Medicine|October 7, 2024
Causal Inference Over a Subpopulation: The Effect of Malaria Vaccine in Women During PregnancyZonghui Hu, Dean Follmann
The International Journal of Biostatistics|April 14, 2012
Bounds on the effect of vaccine induced immune response on outcomeDean Follmann, Michael Fay
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Statistics in Medicine|August 10, 2018
Reliably picking the best endpointDean Follmann
Statistics in Medicine|May 8, 2021
CommentDean Follmann
Biometrics|September 16, 2021
Discussion on "estimating vaccine efficacy over time after a randomized study is unblinded" by Anastasios A. Tsiatis and Marie DavidianDean Follmann
Biometrics|December 13, 2006
Augmented designs to assess immune response in vaccine trialsDean Follmann
Biometrics|January 8, 2011
An augmented probit model for missing predictable covariates in quantal bioassay with small sample sizeDean Follmann, Martha Nason
Biometrics|November 26, 2009
Design and analysis of crossover trials for absorbing binary endpointsMartha Nason, Dean Follmann
Journal of Multivariate Analysis|November 30, 2011
A test of location for exchangeable multivariate normal data with unknown correlationDean Follmann, Michael Proschan
Biostatistics (Oxford, England)|August 14, 2024
Exposure proximal immune correlates analysisYing Huang, Dean Follmann
Statistics in Medicine|October 7, 2024
Causal Inference Over a Subpopulation: The Effect of Malaria Vaccine in Women During PregnancyZonghui Hu, Dean Follmann
The International Journal of Biostatistics|April 14, 2012
Bounds on the effect of vaccine induced immune response on outcomeDean Follmann, Michael Fay
Pageof 15